ArteraAI Prostate uses digital pathology images from a patient’s biopsy to predict potential long-term outcomes of their prostate cancer.

The companies will develop AI models trained on real-world data to help identify and diagnose patients with paroxysmal nocturnal hemoglobinuria.

The company will use the funds to open a new headquarters in the Bay Area, scale its reach and platform, and expand its ...

The financing comes on top of the company's $900 million annual research and development investment in the U.S.

Brain health and dementia care platform Isaac Health has secured $10.5 million in Series A funding, bringing its total raise ...

Latest studies have demonstrated high AI accuracies in predicting cancer recurrence and spotting minor colon polyps.

An integrated AI, telemedicine, and Internet of Things system for the ICU has brought down the overall mortality rate in ...

Cole Zanetti, professor and director of digital health at Rocky Vista University College of Osteopathic Medicine, says AI can ...

The future of EMR systems is powered by AI, according to Oracle Health APAC's chief clinical CIO Michael Draheim.

Maven Clinic introduces male fertility support tools, Scripta Insights announces a tool to locate cost-effective meds, and ...

PhnyX Lab, a startup backed by one of South Korea's largest conglomerates, SK Group, has recently raised $4 million in seed ...

The Microdose GLP-1Rx Program will offer low-dose GLP-1 prescriptions combined with behavioral coaching, clinical monitoring ...